These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 31346894)

  • 1. ADPKD and metformin: from bench to bedside.
    Capuano I; Riccio E; Caccavallo S; De Simone I; Pisani A
    Clin Exp Nephrol; 2019 Nov; 23(11):1341-1342. PubMed ID: 31346894
    [No Abstract]   [Full Text] [Related]  

  • 2. Metformin in autosomal dominant polycystic kidney disease: experimental hypothesis or clinical fact?
    Pisani A; Riccio E; Bruzzese D; Sabbatini M
    BMC Nephrol; 2018 Oct; 19(1):282. PubMed ID: 30348113
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A single-arm pilot study of metformin in patients with autosomal dominant polycystic kidney disease.
    Sorohan BM; Ismail G; Andronesi A; Micu G; Obrișcă B; Jurubiță R; Sinescu I; Baston C
    BMC Nephrol; 2019 Jul; 20(1):276. PubMed ID: 31337351
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of diabetes in the elderly. Is there anything to improve?
    Pinés-Corrales PJ; Ibáñez-Navarro P; Vicente-Albiñana Á; Sáez-Valencia G
    Endocrinol Diabetes Nutr (Engl Ed); 2018 May; 65(5):308-309. PubMed ID: 29602627
    [No Abstract]   [Full Text] [Related]  

  • 5. Effect of Tolvaptan in Autosomal Dominant Polycystic Kidney Disease by CKD Stage: Results from the TEMPO 3:4 Trial.
    Torres VE; Higashihara E; Devuyst O; Chapman AB; Gansevoort RT; Grantham JJ; Perrone RD; Ouyang J; Blais JD; Czerwiec FS;
    Clin J Am Soc Nephrol; 2016 May; 11(5):803-811. PubMed ID: 26912543
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Kidney Function Reserve Capacity in Early and Later Stage Autosomal Dominant Polycystic Kidney Disease.
    Messchendorp AL; van Londen M; Taylor JM; de Borst MH; Navis G; Casteleijn NF; Gaillard CAJM; Bakker SJL; Gansevoort RT;
    Clin J Am Soc Nephrol; 2018 Nov; 13(11):1680-1692. PubMed ID: 30254028
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Polycystic kidney disease: a 2011 update.
    Steinman TI
    Curr Opin Nephrol Hypertens; 2012 Mar; 21(2):189-94. PubMed ID: 22274800
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Yinang formulation versus placebo granules as a treatment for chronic kidney disease stages III-IV in patients with autosomal dominant polycystic kidney disease: study protocol for a double-blind placebo-controlled randomized clinical trial.
    Gan J; Wu Y; Gong X; Ma Y; Yu S; Gao J
    Trials; 2019 Aug; 20(1):481. PubMed ID: 31391092
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Inhibitors of intra-cystic secretion: novel therapies in ADPKD (Autosomal Dominant Polycystic Kidney Disease)].
    Miranda N; Miranda F; Rinaldi L; Stratigis S; Capasso G
    G Ital Nefrol; 2013; 30(1):. PubMed ID: 23832438
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Age, renal dysfunction, cardiovascular disease, and antihyperglycemic treatment in type 2 diabetes mellitus: findings from the Renal Insufficiency and Cardiovascular Events Italian Multicenter Study.
    Solini A; Penno G; Bonora E; Fondelli C; Orsi E; Trevisan R; Vedovato M; Cavalot F; Cignarelli M; Morano S; Ferrannini E; Pugliese G;
    J Am Geriatr Soc; 2013 Aug; 61(8):1253-61. PubMed ID: 23889588
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationship of urinary endothelin-1 with estimated glomerular filtration rate in autosomal dominant polycystic kidney disease: a pilot cross-sectional analysis.
    Raina R; Lou L; Berger B; Vogt B; Do AS; Cunningham R; Vasavada P; Herrmann K; Dell K; Simonson M
    BMC Nephrol; 2016 Feb; 17():22. PubMed ID: 26923419
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Results of treatment of adult diabetes mellitus with Metformin-sulfonamide combination (apropos of 197 cases)].
    Debry G; Laurent J
    J Med Lyon; 1966 Mar; 47(94):407-13. PubMed ID: 5909923
    [No Abstract]   [Full Text] [Related]  

  • 13. Determinants of Progression in Early Autosomal Dominant Polycystic Kidney Disease: Is it Blood Pressure or Renin-Angiotensin-Aldosterone-System Blockade?
    Brosnahan GM; Abebe KZ; Moore CG; Bae KT; Braun WE; Chapman AB; Flessner MF; Harris PC; Hogan MC; Perrone RD; Rahbari-Oskoui FF; Steinman TI; Torres VE; The Halt Pkd Investigators
    Curr Hypertens Rev; 2018; 14(1):39-47. PubMed ID: 29564978
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Baseline total kidney volume and the rate of kidney growth are associated with chronic kidney disease progression in Autosomal Dominant Polycystic Kidney Disease.
    Yu ASL; Shen C; Landsittel DP; Harris PC; Torres VE; Mrug M; Bae KT; Grantham JJ; Rahbari-Oskoui FF; Flessner MF; Bennett WM; Chapman AB;
    Kidney Int; 2018 Mar; 93(3):691-699. PubMed ID: 29290310
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dietary salt restriction is beneficial to the management of autosomal dominant polycystic kidney disease.
    Torres VE; Abebe KZ; Schrier RW; Perrone RD; Chapman AB; Yu AS; Braun WE; Steinman TI; Brosnahan G; Hogan MC; Rahbari FF; Grantham JJ; Bae KT; Moore CG; Flessner MF
    Kidney Int; 2017 Feb; 91(2):493-500. PubMed ID: 27993381
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metformin lowers lipoprotein(a) levels.
    Bell DS; Ovalle F
    Diabetes Care; 1998 Nov; 21(11):2028. PubMed ID: 9802762
    [No Abstract]   [Full Text] [Related]  

  • 17. [Clinical research on a new hypoglycemic drug combination: glycyclamide and dimethylbiguanide].
    Cucurachi P; Dell'Anna A
    Clin Ter; 1968 May; 45(4):363-73. PubMed ID: 5738669
    [No Abstract]   [Full Text] [Related]  

  • 18. TAMEing ADPKD with metformin: safe and effective?
    Ong ACM; Gansevoort RT
    Kidney Int; 2021 Sep; 100(3):513-515. PubMed ID: 34420660
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ERBP guideline on management of patients with diabetes and chronic kidney disease stage 3B or higher. Metformin for all?
    Martínez-Castelao A; Górriz JL; Ortiz A; Navarro-González JF
    Nefrologia; 2017; 37(6):567-571. PubMed ID: 28669489
    [No Abstract]   [Full Text] [Related]  

  • 20. Efficacy of metformin in the treatment of diabetes mellitus complicating thalassemia major.
    Dhouib N; Turki Z; Mellouli F; Ouederni M; Yahiaoui S; Nagi S; Ben Slama C; Bejaoui M
    Tunis Med; 2010 Feb; 88(2):136. PubMed ID: 20415181
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.